Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. They are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients’ lives. 

Biotechnology

Dermavant Sciences

Carey Herbert

Ashley Inda

Kenneth Peist

Raz Malik

Chuck McAllister

Jennifer McCormack

Krista Skidmore

Natalie Miller-Ritt

Neil Fujita

Beth Riley

Philip M Brown

Chris Chapman

David Rubenstein

Paul Seaback

Michael Swartzburg

Darren Lenczycki

Brad Seddon

George David

Adam Pardo

Christopher Hammond

Bill Matz

Bob Becker

Brad McClanahan

Bruce Alexander

Catherine Hadley

Chelsea Steed Murphy

Christina Stewart

Christine Hayes

Christopher Zoghby

Sales and Marketing

Medical Affairs and Clinical Operations

Leadership Team

Legal and Compliance

Teams at Dermavant Sciences

Sales and Marketing

Medical Affairs and Clinical Operations

Leadership Team

Legal and Compliance